Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra‐performance liquid chromatography–tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy
Biomedical Chromatography · 2024-02 · 38 (2)
DOI: 10.1002/bmc.5777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 22.11.2023. Verfasst von Mengyu Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China. Hauptthemen laut MEDLINE: Pregnant People, Epilepsy, Formates. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Sichuan Science and Technology Program, Youth Program of the National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Although levetiracetam (LEV) has favorable linear pharmacokinetic properties, therapeutic drug monitoring (TDM) is necessary for pregnant women with epilepsy. This study aims to build a simple, reliable, and sensitive ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method for determining LEV concentrations in plasma and saliva samples, to support the routine TDM of LEV in Chinese pregnant women with epilepsy. The stable isotope‐labeled LEV‐d 6 was used as the internal standard. The extracted samples were analyzed using a UPLC–MS/MS system with positive electrospray ionization. Mobile phase A was water containing 5 mM ammonium acetate and 0.1% formic acid, and phase B was 1:1 methanol–acetonitrile with 0.1% formic acid. The method was validated and utilized to determine LEV concentrations in non‐pregnant and pregnant patients with epilepsy. The developed method was validated in both plasma and saliva samples over a concentration range of 0.1–50 μg/mL. The intra‐ and inter‐batch accuracy for LEV ranged from −7.0% to 2.9%, with precisions between 2.7% and 9.3%. In pregnant patients, the mean dose‐standardized LEV trough plasma concentrations were significantly lower than those in non‐pregnant patients (4.73 ± 2.99 vs. 7.74 ± 3.59 ng/mL per mg/day; P < 0.0001). It is recommended that the TDM of LEV should be routinely performed during the different stages of pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
- Department of Pharmacy, NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
- Clinical Trial Center, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China.
Förderung
- Sichuan Science and Technology Program
- Youth Program of the National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
Zitieren
APA
Zhang, M., Jin, Y., Li, W., He, C., Di, X., Duan, Y., Chen, L., & Wang, Z. (2024). Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra‐performance liquid chromatography–tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy. Biomedical Chromatography, 38(2). https://doi.org/10.1002/bmc.5777
Vancouver
Zhang M, Jin Y, Li W, He C, Di X, Duan Y, et al. Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra‐performance liquid chromatography–tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy. Biomedical Chromatography. 2024;38(2). doi:10.1002/bmc.5777
BibTeX
@article{Zhang2024,
author = {Zhang, Mengyu and Jin, Ying and Li, Wanling and He, Chaoqun and Di, Xiangjie and Duan, Yifei and Chen, Lei and Wang, Zhenlei},
title = {Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra‐performance liquid chromatography–tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy},
journal = {Biomedical Chromatography},
year = {2024},
volume = {38},
number = {2},
doi = {10.1002/bmc.5777}
}
EUVIMED